Ford Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,768
Closed -$110 166
2021
Q4
$110 Buy
+1,768
New +$104K 0.02% 156
2021
Q3
Sell
-1,917
Closed -$128K 166
2021
Q2
$128K Buy
+1,917
New +$125K 0.05% 137
2020
Q3
Sell
-3,622
Closed -$213K 90
2020
Q2
$213K Buy
3,622
+32
+0.9% +$1.91K 0.12% 84
2020
Q1
$200K Buy
+3,590
New +$219K 0.13% 82
2018
Q1
Sell
-465
Closed -$28K 90
2017
Q4
$28K Buy
+465
New +$29.1K 0.02% 127

Other funds holding BMY

Ford Financial Group's BMY Position: Q1 2022 in Review

Ford Financial Group sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 1,768 shares — an estimated $110 sold.

Ford Financial Group first reported a position in BMY in Q4 2017 and held it in 5 quarters. The position peaked at $213K in Q2 2020. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • Ford Financial Group reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 1,768 Bristol-Myers Squibb shares in Q1 2022, an estimated $110.
  • Ford Financial Group first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 5 quarters.
  • Ford Financial Group's Bristol-Myers Squibb position peaked at $213K in Q2 2020.
  • 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.